Sandrine Miller-Montgomery, Pharm.D., Ph.D.

Co-founder, Board member, President, and CEO 

Sandrine brings a wealth of experience to Micronoma, having worked at large biotech and multinational companies in the life science industry, as well as start-ups. She has assumed different responsibilities from R&D director to leading sales and marketing organizations and excels at preparing companies for successful exits.

Before co-founding Micronoma, she was executive director of UC San Diego’s Center for Microbiome Innovation (CMI), which she co-led with renowned microbiome researcher, Dr. Rob Knight. Sandrine established a world-class team focused on expanding industry and academic collaborations in the field of microbiome research that resulted in raising more than tens of millions of dollars of financial support through key partnerships toward application of this science to AI, diet and nutrition, aging, environment, human disease understanding and more.

Sandrine has a talent for assembling efficient and successful teams around innovative products as shown by her work at Helixis, acquired by Illumina, and Mo Bio Labs acquired by QIAGEN.

Greg Sepich-Poore, Ph.D.

Co-founder, Chief Analytics Officer

At only 29 years old, Micronoma is Greg’s 2^nd medical technology corporation and was inspired by the unexpected stage IV diagnosis and tragic sudden loss of his grandmother to pancreatic cancer. Additionally, Greg founded a non-profit corporation at age 18 to provide educational opportunities to underprivileged and foster youth in South Florida, and then co-founded his first med tech company, Vigor Medical Systems, at age 22 to help patients better manage their lung conditions. Greg has led and co-authored peer-reviewed papers in Nature, Science, and Cell, is inventor on multiple filed patents, and was awarded an NIH fellowship funding during his Ph.D. for his research on the cancer microbiome. He was also selected by Forbes for the 30 Under 30 list in Healthcare for 2023. In his spare time, Greg loves to do triathlons and completed his first Ironman in Arizona in 2019.

Rob Knight, Ph.D.

Co-founder, Micronoma Scientific Advisory Board member

He is the author of “Follow Your Gut: The Enormous Impact of Tiny Microbes” (Simon & Schuster, 2015), coauthor of “Dirt is Good: The Advantage of Germs for Your Child’s Developing Immune System” (St. Martin’s Press, 2017), and his TED talk presentation in 2014 was viewed more than 2 million times.

He is co-founder of the Earth Microbiome Project and the American Gut Project.

Darryl Garrison, M.S.

Chief Operations Officer

Darryl’s 20-plus years of experience in the molecular diagnostic industry include extensive work setting up and running molecular clinical laboratories and establishing CLIA diagnostics laboratories at many of the major clinical cancer diagnostic laboratories in Southern California, including Clarient, Neogenomics, Pathway Genomics, Arista Molecular, Vantagepoint Laboratories, Biological Dynamics, and DermTech. Darryl manages all aspects of the company’s service lab, including the design and build-out of the laboratory space from the ground up, acquiring CLIA and state laboratory licenses and establishing robust quality systems.

Darryl also directs and manages all aspects of CLIA lab operations to ensure that the highest levels of analytic performance are maintained. Darryl also approves biomarker assay development plans through coordination with product development, commercial operations, and technical support.

Todd Czerwinski, B.S.

Vice President of Business Development

Todd has built a 27-year career in business and market development for innovative life science technologies that includes developing teams and processes for both growing and established companies creating strategic partnerships and building consensus across organizational levels.

Prior to joining Micronoma, Todd was the senior director of sales at DNA Genotek, where he directed a team of nineteen account managers and was responsible for growing the revenues of their microbiome, human genomics, and animal health products around the world. 

Todd also served as director of national sales and the global OEM accounts manager at QIAGEN North America after their acquisition of Mo Bio laboratories where he led the sales team’s revenue growth and account management of all U.S. based sales of the microbiome line of consumables

Todd holds a Bachelor of Science degree in cellular and developmental biology from Michigan State University.

Eddie Adams, Ph.D.

Chief Scientific Officer

An expert in nucleic acid chemistry, molecular diagnostics, product development, and R&D management, Eddie has a proven track record of driving innovation and motivating teams focused on immunology, and nucleic acid chemistry, nanotechnology, and disease diagnostics.

Before joining Micronoma, Eddie was vice president of R&D at Active Motif, leading the development of all new products and services for epigenetic analysis. Prior to that, he was director of R&D at Mo Bio Laboratories (acquired by QIAGEN), where he developed products for the extraction/isolation of DNA, RNA, and proteins from complex matrices such as microbiome samples. That work led to the filing of six patent applications covering new methods of PCR inhibitor depletion, chemistries for high throughput protein isolation, and novel approaches to nucleic acid size selection for next generation sequencing library preparation.  

Eddie’s experience also includes several roles at nanoMR, most recently as director of molecular diagnostics, following work as an investigator for Novartis Institutes for Biomedical Research and as a staff scientist at Quantum Dot Corp.